Natera (NTRA) News Today $162.31 -5.88 (-3.50%) Closing price 04:00 PM EasternExtended Trading$160.64 -1.67 (-1.03%) As of 05:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Ieq Capital LLC Purchases 51,637 Shares of Natera, Inc. (NASDAQ:NTRA)Ieq Capital LLC lifted its position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 551.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 61,005 shares of the medical research company's stock after aFebruary 21 at 4:45 AM | marketbeat.comRhumbline Advisers Sells 1,620 Shares of Natera, Inc. (NASDAQ:NTRA)Rhumbline Advisers cut its position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 1.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 138,281 shares of the medical research company's stock after selling 1,620 shFebruary 21 at 3:32 AM | marketbeat.comVontobel Holding Ltd. Lowers Stake in Natera, Inc. (NASDAQ:NTRA)Vontobel Holding Ltd. lessened its position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 42.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,083 shares of the medical research company's stFebruary 21 at 3:24 AM | marketbeat.comAlberta Investment Management Corp Sells 5,011,459 Shares of Natera, Inc. (NASDAQ:NTRA)Alberta Investment Management Corp trimmed its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 99.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 30,981 shares of the medical research company's stock after selling 5,01February 20 at 4:54 AM | marketbeat.comNatera (NTRA) Surged on Blowout Quarterly ResultsFebruary 19 at 1:27 PM | msn.comNatera, Inc. (NASDAQ:NTRA) Shares Sold by Principal Financial Group Inc.Principal Financial Group Inc. lessened its holdings in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 31.4% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 694,667 shares of the medical research company's stock after selling 31February 19 at 4:39 AM | marketbeat.comNatera (NTRA) Expected to Announce Quarterly Earnings on WednesdayNatera (NASDAQ:NTRA) will be releasing earnings after the market closes on Wednesday, February 26.February 19 at 3:08 AM | marketbeat.comAmerican Century Small Cap Growth Fund Q4 2024 CommentaryFebruary 18 at 11:38 PM | seekingalpha.comNatera, Inc. (NASDAQ:NTRA) Shares Sold by Kornitzer Capital Management Inc. KSKornitzer Capital Management Inc. KS decreased its holdings in Natera, Inc. (NASDAQ:NTRA - Free Report) by 35.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 106,119 shares of the medical research company's stock after sellinFebruary 18 at 5:52 AM | marketbeat.comNatera, Inc. (NASDAQ:NTRA) Receives Average Rating of "Buy" from AnalystsNatera, Inc. (NASDAQ:NTRA - Get Free Report) has received a consensus rating of "Buy" from the seventeen analysts that are presently covering the company, MarketBeat reports. Seventeen analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that have issueFebruary 17, 2025 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) Shares Acquired by Van ECK Associates CorpVan ECK Associates Corp increased its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 17.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 119,673 shares of the medical research company'February 16, 2025 | marketbeat.comChevy Chase Trust Holdings LLC Raises Stake in Natera, Inc. (NASDAQ:NTRA)Chevy Chase Trust Holdings LLC grew its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 14.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 549,871 shares of the medical research company's stock after purchaFebruary 15, 2025 | marketbeat.comBanque Pictet & Cie SA Trims Stock Position in Natera, Inc. (NASDAQ:NTRA)Banque Pictet & Cie SA lowered its position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 10.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,180 shares of the medical reseFebruary 15, 2025 | marketbeat.comQuent Capital LLC Sells 3,008 Shares of Natera, Inc. (NASDAQ:NTRA)Quent Capital LLC lessened its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 94.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 175 shares of the medical research company's stock after selling 3,008 shFebruary 14, 2025 | marketbeat.comAllspring Global Investments Holdings LLC Has $178.81 Million Stake in Natera, Inc. (NASDAQ:NTRA)Allspring Global Investments Holdings LLC cut its holdings in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 9.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,113,748 shares of the medical research company'sFebruary 12, 2025 | marketbeat.com11,294 Shares in Natera, Inc. (NASDAQ:NTRA) Purchased by Guided Capital Wealth Management LLCGuided Capital Wealth Management LLC acquired a new position in Natera, Inc. (NASDAQ:NTRA - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 11,294 shares of the medical research company's stock, valued at approximately $February 12, 2025 | marketbeat.comEmpowered Funds LLC Lowers Position in Natera, Inc. (NASDAQ:NTRA)Empowered Funds LLC trimmed its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 9.1% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 38,118 shares of the medical research company's stock after selling 3,836 shares during theFebruary 11, 2025 | marketbeat.comabrdn plc Has $1.02 Million Stock Holdings in Natera, Inc. (NASDAQ:NTRA)abrdn plc decreased its stake in Natera, Inc. (NASDAQ:NTRA - Free Report) by 81.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,435 shares of the medical research company's stock after selling 27,8February 11, 2025 | marketbeat.comNatera comments on updated NCCN guidance for circulating tumor DNAFebruary 11, 2025 | markets.businessinsider.comCanaccord maintains $180 target on Natera stock post-NCCN updateFebruary 11, 2025 | msn.comNCCN Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell CarcinomaFebruary 10, 2025 | businesswire.comSumitomo Mitsui Trust Group Inc. Purchases 69,455 Shares of Natera, Inc. (NASDAQ:NTRA)Sumitomo Mitsui Trust Group Inc. grew its position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 10.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 740,837 shares of the medical research company's stock afteFebruary 9, 2025 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) Insider Sells $117,861.51 in StockFebruary 8, 2025 | insidertrades.comLecap Asset Management Ltd. Lowers Holdings in Natera, Inc. (NASDAQ:NTRA)Lecap Asset Management Ltd. reduced its stake in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 45.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,853 shares of the medicalFebruary 8, 2025 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) Shares Sold by Mirae Asset Global Investments Co. Ltd.Mirae Asset Global Investments Co. Ltd. lowered its position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 45.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 51,701 shares of the medical research company's stock after selling 42,869 shares dFebruary 8, 2025 | marketbeat.comNatera president sells $290,120 in common stockFebruary 7, 2025 | msn.comNatera's president sells shares worth $117,861February 7, 2025 | msn.comNatera, Inc. (NASDAQ:NTRA) Insider John Fesko Sells 663 SharesNatera, Inc. (NASDAQ:NTRA - Get Free Report) insider John Fesko sold 663 shares of Natera stock in a transaction on Thursday, February 6th. The shares were sold at an average price of $177.77, for a total transaction of $117,861.51. Following the completion of the transaction, the insider now directly owns 156,044 shares in the company, valued at $27,739,941.88. The trade was a 0.42 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.February 7, 2025 | marketbeat.comNatera CFO sells shares worth $7.76 millionFebruary 5, 2025 | msn.comCalamos Advisors LLC Decreases Stock Position in Natera, Inc. (NASDAQ:NTRA)Calamos Advisors LLC lowered its position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 99.8% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 22,970 shares of the medical research company's stock after selliFebruary 5, 2025 | marketbeat.comChicago Partners Investment Group LLC Buys New Shares in Natera, Inc. (NASDAQ:NTRA)Chicago Partners Investment Group LLC bought a new stake in Natera, Inc. (NASDAQ:NTRA - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 1,878 shares of the medical research company's stock, valued at approximFebruary 5, 2025 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) CFO Sells $7,694,633.76 in StockNatera, Inc. (NASDAQ:NTRA - Get Free Report) CFO Michael Burkes Brophy sold 43,502 shares of the firm's stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $176.88, for a total value of $7,694,633.76. Following the transaction, the chief financial officer now owns 70,629 shares of the company's stock, valued at approximately $12,492,857.52. The trade was a 38.12 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.February 4, 2025 | marketbeat.comBillionaire Stanley Druckenmiller says the AI boom could get much bigger – These are the stocks he ownsFebruary 4, 2025 | 247wallst.comGDS Wealth Management Raises Position in Natera, Inc. (NASDAQ:NTRA)GDS Wealth Management grew its position in Natera, Inc. (NASDAQ:NTRA - Free Report) by 245.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 12,463 shares of the medical research companyFebruary 4, 2025 | marketbeat.comHodges Capital Management Inc. Invests $372,000 in Natera, Inc. (NASDAQ:NTRA)Hodges Capital Management Inc. purchased a new stake in Natera, Inc. (NASDAQ:NTRA - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 2,350 shares of the medical research company's stoFebruary 4, 2025 | marketbeat.comJennison Associates LLC Has $120.95 Million Position in Natera, Inc. (NASDAQ:NTRA)Jennison Associates LLC lessened its holdings in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 1.0% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 764,056 shares of the medical research company's stock after selling 7,906 shares during the period. JeFebruary 4, 2025 | marketbeat.comMichael Burkes Brophy Sells 4,335 Shares of Natera, Inc. (NASDAQ:NTRA) StockFebruary 4, 2025 | insidertrades.comNatera announces national commercial coverage for Fetal RhD NIPTFebruary 3, 2025 | markets.businessinsider.comNatera, Inc. (NASDAQ:NTRA) CFO Sells $719,046.45 in StockNatera, Inc. (NASDAQ:NTRA - Get Free Report) CFO Michael Burkes Brophy sold 4,335 shares of the firm's stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $165.87, for a total value of $719,046.45. Following the sale, the chief financial officer now directly owns 103,697 shares of the company's stock, valued at $17,200,221.39. The trade was a 4.01 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link.February 3, 2025 | marketbeat.comSYM FINANCIAL Corp Purchases Shares of 1,615 Natera, Inc. (NASDAQ:NTRA)SYM FINANCIAL Corp purchased a new position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 1,615 shares of the medical research company's stock,February 3, 2025 | marketbeat.comSwedbank AB Acquires 10,326 Shares of Natera, Inc. (NASDAQ:NTRA)Swedbank AB raised its holdings in Natera, Inc. (NASDAQ:NTRA - Free Report) by 51.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 30,326 shares of the medical research company's stock after buying an additional 10,326 sFebruary 2, 2025 | marketbeat.comSeaBridge Investment Advisors LLC Makes New Investment in Natera, Inc. (NASDAQ:NTRA)SeaBridge Investment Advisors LLC bought a new stake in Natera, Inc. (NASDAQ:NTRA - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 18,282 shares of the medical research company's stocFebruary 1, 2025 | marketbeat.comInsider Selling: Natera, Inc. (NASDAQ:NTRA) CFO Sells 1,886 Shares of StockFebruary 1, 2025 | insidertrades.comMichael Burkes Brophy Sells 1,886 Shares of Natera, Inc. (NASDAQ:NTRA) StockNatera, Inc. (NASDAQ:NTRA - Get Free Report) CFO Michael Burkes Brophy sold 1,886 shares of the firm's stock in a transaction dated Friday, January 31st. The stock was sold at an average price of $176.60, for a total value of $333,067.60. Following the completion of the transaction, the chief financial officer now owns 101,811 shares in the company, valued at approximately $17,979,822.60. This trade represents a 1.82 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.January 31, 2025 | marketbeat.comInsider Selling: Natera, Inc. (NASDAQ:NTRA) Insider Sells 5,201 Shares of StockNatera, Inc. (NASDAQ:NTRA - Get Free Report) insider Solomon Moshkevich sold 5,201 shares of the firm's stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $165.87, for a total transaction of $862,689.87. Following the completion of the transaction, the insider now owns 135,483 shares in the company, valued at $22,472,565.21. The trade was a 3.70 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.January 31, 2025 | marketbeat.comInsider Selling: Natera, Inc. (NASDAQ:NTRA) CEO Sells 13,685 Shares of StockNatera, Inc. (NASDAQ:NTRA - Get Free Report) CEO Steven Leonard Chapman sold 13,685 shares of the firm's stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $165.87, for a total value of $2,269,930.95. Following the completion of the sale, the chief executive officer now directly owns 253,944 shares in the company, valued at approximately $42,121,691.28. The trade was a 5.11 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.January 31, 2025 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) CFO Sells $233,416.54 in StockJanuary 31, 2025 | insidertrades.comGries Financial LLC Takes Position in Natera, Inc. (NASDAQ:NTRA)Gries Financial LLC purchased a new position in Natera, Inc. (NASDAQ:NTRA - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 1,804 shares of the medical research company's stock, valued at approJanuary 31, 2025 | marketbeat.comBaader Bank Aktiengesellschaft Buys Shares of 2,850 Natera, Inc. (NASDAQ:NTRA)Baader Bank Aktiengesellschaft purchased a new position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 2,850 shares of the medical research company's stock, valued atJanuary 31, 2025 | marketbeat.comNatera, Inc. (NASDAQ:NTRA) Shares Purchased by KBC Group NVKBC Group NV boosted its position in shares of Natera, Inc. (NASDAQ:NTRA - Free Report) by 753.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 27,551 shares of the medical research company's stock afterJanuary 31, 2025 | marketbeat.com Get Natera News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter. Email Address NTRA Media Mentions By Week NTRA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NTRA News Sentiment▼1.350.60▲Average Medical News Sentiment NTRA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NTRA Articles This Week▼1310▲NTRA Articles Average Week Get Natera News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FMS News Today HIMS News Today GH News Today OPCH News Today RDNT News Today BTSG News Today SHC News Today SGRY News Today VCYT News Today LFST News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NTRA) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Natera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Natera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NTRA Stock Alerts